HEB, Hemispherx Biopharma (AMEX)NEW Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : HEB, Hemispherx Biopharma (AMEX)NEW

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: LORD ERNIE who wrote (647)	3/10/1999 12:01:00 PM
From: Bart Goemaere	Read Replies (1) of 857

Hi Ernie, That's already old news... New news (from the meeting with Dr. Carter in Brussels) : A new company is set up named : Core Biotech Company. This company is the spin-off from HEB that is searching for a cure again HEP B/C. Each shareholder will get some shares from Core as a non-taxed dividend. This company will get it's funding from some South-East Asian Investment bankers (probably) to do more research on HEP B/C. With regard to HEB. Dr. Carter said they are searching for quoting the stock on Easdaq. These shares will come from some warrants that will be exercised. Approval for Ampligen is expected somewhere around August. The team around HEB-Europe has been strengthened by 2 guys who's name I do not remember anymore (but they had some pretty good experience in the pharmaceutical world, one came from Shering). As far the latest info. Greetings, B.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next